Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02235064 · ClinicalTrials.gov registry record · NA
Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression
A NA study, sponsored by The Cooper Health System.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02235064 is a NA study that was terminated before completion, run by The Cooper Health System. The registered enrollment target is 2 participants.
The verdict
NCT02235064, a NA study, was terminated before completion, sponsored by The Cooper Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this project is to assess the effectiveness of preventative antidepressants immediately following delivery on postpartum depression rates in women at high risk due to prior history of depression or postpartum depression.
Interventions
- DRUG Placebo
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02235064
The ClinicalTrials.gov registry entry for NCT02235064 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02235064 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02235064 about?
NCT02235064 is a clinical study titled "Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression". The purpose of this project is to assess the effectiveness of preventative antidepressants immediately following delivery on postpartum depression rates in women at high risk due to prior history of depression or postpartum depression.
What is the current status of trial NCT02235064?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2014-07. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02235064?
The interventions under investigation include: Placebo (DRUG), Sertraline (DRUG).
Who is sponsoring clinical trial NCT02235064?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.